hc1

hc1 is a bioinformatics company that specializes in transforming complex laboratory data into actionable healthcare insights. Founded in 2011 by Brad Bostic, hc1 aims to advance precision medicine and personalized healthcare through its cloud-based platform. The company's core offering, the hc1 Precision Health Cloud, organizes and analyzes vast amounts of laboratory, genomic, and medication data to create personalized patient profiles at scale.

hc1's suite of solutions includes hc1 Operations Management, hc1 Analytics, hc1 PrecisionDx Advisor, and hc1 PrecisionRx Advisor. These tools are designed to streamline laboratory operations, automate reporting, enable real-time key performance indicator tracking, and support precision testing and prescribing. The platform has processed over 25 billion lab results and generated actionable healthcare insights for more than 160 million patients as of 2021.

The company leverages advanced technologies such as cloud computing, machine learning, and artificial intelligence to deliver its services. As an Amazon Web Services (AWS) healthcare Competency Partner, hc1 utilizes AWS services like AWS Glue and AWS Lake Formation to build a scalable, multi-tenant architecture that can handle large volumes of data across multiple customers.

Key customers and partnerships

hc1's primary customers include medical laboratories, health plans, and health systems. Notable clients using hc1's insights include Quest Diagnostics, Sonora Quest Laboratories, and DrugScan. The company has also formed partnerships with organizations like American Oncology Network (AON) to develop solutions such as hc1 Workforce Optimization.

In response to the Covid-19 pandemic, hc1 collaborated with a coalition of lab partners to launch the CV19 Lab Testing Dashboard. This free public health service provided timely insights into Covid-19 testing rates, results, and demographic data to help healthcare providers and public health officials make informed decisions. The company also worked with Eli Lilly & Company to analyze data from drive-through testing sites, providing valuable insights into infection rates among essential workers.